Tiina Rantsi

Tiina Rantsi

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 May 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
SVSeppo Virtanen
Seppo Virtanen
TRTiina Rantsi
Tiina Rantsi
AVAnni Virtanen
Anni Virtanen
KKKaisa Kervinen
Kaisa Kervinen
PNPekka Nieminen
Pekka Nieminen
ASAnne Salonen
Anne Salonen
Recent research on vaginal microbiota relies on high throughput sequencing while microscopic methods have a long history in clinical use. We investigated the correspondence between microscopic findings of Pap smears and the vaginal microbiota composition determined by next generation sequencing among 50 asymptomatic women. Both methods produced coherent results regarding the distinction betweenLactobacillus-dominant versus mixed microbiota, reassuring gynaecologists for the use of Pap smear or wet mount microscopy for rapid evaluation of vaginal bacteria as part of diagnosis. Cytologic findings identified women with bacterial vaginosis and revealed that cytolysis of vaginal epithelial cells is associated toLactobacillus crispatus-dominated microbiota. Education and socio-economic status were associated to the vaginal microbiota variation. Our results highlight the importance of including socio-economic status as a co-factor in future vaginal microbiota studies.

18 July 2019 in Sexually Transmitted Infections
Verified
Journal Article
Closed access
PDF file
HÖHanna Öhman
Hanna Öhman
TRTiina Rantsi
Tiina Rantsi
PJPäivi Joki-Korpela
Päivi Joki-Korpela
ATAila Tiitinen
Aila Tiitinen
HSHeljä-Marja Surcel
Heljä-Marja Surcel
Objectives: Population-basedChlamydia trachomatisseroepidemiological studies help to identify trends in chlamydia infection. However, an improved understanding of the antibody response to infection is required when using serology to estimate cumulative incidence. Thus, the objectives of this longitudinal, retrospective, biobank-based study were to assess the appearance and persistence ofC. trachomatismajor outer membrane protein (MOMP)-specific serum IgG antibodies after infection and to evaluate the role of antibodies in providing protective immunity against recurrent infection.Methods: Data of notifiedC. trachomatisinfections in Finland were obtained from the National Infectious Diseases Register. Serum samples were acquired from the Finnish Maternity Cohort. 411 women with single chlamydia infection and 62 women with recurrent infections, and for whom suitable paired serum samples were available, were included in the study. Antibody appearance, persistence after infection and the impact of recurrent infections were evaluated. IgG antibodies specific for MOMP were measured from serum using an ELISA method.Results: Anti-C. trachomatisMOMP-specific IgG antibodies were detected in 65.5% (269/411) of women within 3 months of notification of infection. In the absence of recurrent infection, seroprevalence declined to 34.5% (142/411) 3–10 years after the initial infection. The serum antibody levels at baseline correlated positively with seroprevalence at follow-up. Reinfection boosted the humoral immune response by increasing seroprevalence and the serum antibody levels. Seroprevalence within 3 months after first notification of infection was 65.5% (19/29) in women who were later diagnosed with recurrent infection, comparable with women with single notification of infection (65.5%, 269/411).Conclusions: Approximately one-third of women with single notification of chlamydia infection remain seropositive 3–10 years after the initial infection. The concentration of antibodies remained stable during the follow-up. Recurrent infection boosted the humoral immune response, but reinfection occurred despite the presence of pre-existing antibodies.

1 June 2016 in Sexually Transmitted Diseases
Verified
Journal Article
Closed access
TRTiina Rantsi
Tiina Rantsi
PJPäivi Joki-Korpela
Päivi Joki-Korpela
EWErika Wikström
Erika Wikström
HÖHanna Öhman
Hanna Öhman
ABAini Bsc Bloigu
Aini Bsc Bloigu
HSHeljä-Marja Surcel
Heljä-Marja Surcel
Background Chlamydia trachomatis infection is one of the most common sexually transmitted reported bacterial infections worldwide. The well-known sequelae of chlamydial infection include pelvic inflammatory disease and tubal factor infertility, but the evidence linking C. trachomatis infection and adverse pregnancy outcome is inconsistent and has been largely based on case-control studies with limited study populations. We evaluated this link in a population-based longitudinal biobank health registry setting. Methods The association between C. trachomatis major outer membrane protein (MOMP) peptide-specific IgG antibodies and ectopic pregnancy, miscarriage, and preterm delivery was examined in a prospective case-control study nested in the Finnish Maternity Cohort. Ectopic pregnancy and miscarriage cases were identified through the Hospital Discharge Register 1998–2005; cases with preterm deliveries were identified through the Finnish Medical Birth register 1988–2005. Control samples were retrieved from the Finnish Maternity Cohort serum bank. A total of 800 cases of ectopic pregnancy, 800 cases of miscarriage, and 1350 cases of preterm birth were included. Equal number of pregnant women without the outcome diagnosis served as controls. The cases and controls were matched by sampling time, at the serum sampling and postal code district. Results Antichlamydial IgG antibodies were associated with ectopic pregnancy. Positive antibody levels were found in 21.0% of cases and 14.6% of controls (P = 0.001; odds ratio, 1.56; 95% confidence interval, 1.20–2.03). Previous exposure to C. trachomatis, as indicated by serum antibodies, doubled the risk of ectopic pregnancy within age and was highest among women 35 years or older. Antichlamydial IgG antibody rates between the cases with miscarriage (16.3% in cases vs. 16.8% in controls) or preterm delivery (18.1% vs. 18.1%) and controls did not differ. Conclusions Our findings confirm the association between previous exposure to C. trachomatis and ectopic pregnancy. We found no association between C. trachomatis seropositivity and miscarriage or preterm birth.

3 October 2018 in American Journal of Reproductive Immunology
Verified
Journal Article
Closed access
PDF file
TRTiina Rantsi
Tiina Rantsi
HÖHanna Öhman
Hanna Öhman
MPMirja Puolakkainen
Mirja Puolakkainen
ABAini Bloigu
Aini Bloigu
JPJorma Paavonen
Jorma Paavonen
PJPäivi Joki‐Korpela
Päivi Joki‐Korpela

18 May 2018 in European Journal of Clinical Microbiology & Infectious Diseases
Verified
Journal Article
Open access
PDF file
TRTiina Rantsi
Tiina Rantsi
PJP. Joki-Korpela
P. Joki-Korpela
KHK. Hokynar
K. Hokynar
IKI. Kalliala
I. Kalliala
HÖH. Öhman
H. Öhman
MPMirja Puolakkainen
Mirja Puolakkainen
Persistent genital chlamydial infection may lead to tubal factor infertility (TFI). Chlamydia trachomatis TroA and HtrA are proteins expressed during persistent chlamydial infection in vitro. We studied serum IgG antibody response against these proteins by EIA in women with TFI and in subfertile women without tubal pathology. Altogether, 22 of 258 subfertile women (8.5%) had TFI which was unilateral in 17 cases and bilateral in 5 cases. Overall, 55 (21.3%) of the 258 women had TroA and 39 (15.1%) had HtrA antibodies. Seropositivity to TroA and HtrA was more common among women with TFI than women with other causes for subfertility (45.5 vs. 19.1%, p = 0.004 for TroA; 36.4 vs. 13.1%, p = 0.004 for HtrA). Mean absorbance values and the prevalence of TroA and HtrA antibodies increased with increasing severity of TFI. On the basis of our results, TroA and HtrA serology has the potential to be further developed to a specific biomarker for C. trachomatis-related TFI.

25 April 2018 in American Journal of Reproductive Immunology
Verified
Journal Article
Open access
PDF file
TRTiina Rantsi
Tiina Rantsi
PJPäivi Joki‐Korpela
Päivi Joki‐Korpela
HÖHanna Öhman
Hanna Öhman
ABAini Bloigu
Aini Bloigu
IKIlkka Kalliala
Ilkka Kalliala
ATAila Tiitinen
Aila Tiitinen
Problem: What is the role of past Chlamydia trachomatis infection in unexplained infertility?Method of study: This is a prospective study of the impact of past C. trachomatis infection on pregnancy rates in 96 women with unexplained infertility. Both humoral and cell‐mediated immune responses (CMI) against C. trachomatis were studied. Serum C. trachomatis IgG antibodies were analyzed using major outer membrane protein (MOMP) peptide‐based ELISA. CMI was studied by lymphocyte proliferation (LP) assay in vitro. Data on given fertility treatment, time to pregnancy, and pregnancy outcome were collected.Results: Altogether, 11.5% of the 96 women had C. trachomatis IgG antibodies. LP response to C. trachomatis was positive in 62.9% women. The overall pregnancy rate or live birth rate did not differ by the presence of antichlamydial antibodies or CMI against C. trachomatis. Time to spontaneous pregnancy was longer among C. trachomatis sero‐positive women than among sero‐negative women (2.9 years vs 2.0 years, P = .03).Conclusion: Past chlamydial infection does not play a major role in unexplained infertility. Women with unexplained infertility and positive immune response to C. trachomatis do not have reduced pregnancy rates, but time to spontaneous pregnancy is longer among C. trachomatis IgG sero‐positive women than among sero‐negative women.